Spirooxindol-1,3-oxazine Alkaloids: Highly Potent and Selective Antitumor Agents Evolved from Iterative Structure Optimization.

Authors:
Eichhorst A; Gallhof M; Voss A; Sekora A; Eggers L and 4 more

Journal:
ChemMedChem

Publication Year: 2022

DOI:
10.1002/cmdc.202200162

PMCID:
PMC9400852

PMID:
35491398

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"Annika Eichhorst is grateful for a Ph.D. scholarship of the Landesgraduiertenförderung, University of Rostock, State of Mecklenburg‐Vorpommern, Germany. Le Thi Huyen thanks the “RoHan” program between the University of Rostock and Vietnam National University ‐ Hanoi University of Science for a research scholarship, which was funded by the German Academic Exchange Service (DAAD, project no. 57315854) and the Federal Ministry for Economic Cooperation and Development (BMZ) inside the framework “SDG Bilateral Graduate school program”. We would further like to thank Michael Müller and Wendy Bergmann (Department of Core Facility for Cell Sorting and Cell Analysis, Rostock University Medical Center, Germany) for the possibility of Flow Cytometry device usage and technical support. We also thank Dipl.‐Biol. Beate Wiebeck for evaluating the morphological characterization results. Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025